Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36244673)

  • 1. Excessive HSP70/TLR2 activation leads to remodeling of the tumor immune microenvironment to resist chemotherapy sensitivity of mFOLFOX in colorectal cancer.
    Feng H; Guo Z; Chen X; Liu K; Li H; Jia W; Wang C; Luo F; Ji X; Zhang T; Zhao R; Cheng X
    Clin Immunol; 2022 Dec; 245():109157. PubMed ID: 36244673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
    Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
    BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the role of T-cell exhaustion-related genes in colorectal cancer: a single-cell bioinformatics perspective.
    Tu W; Tu Y; Tan C; Zhong H; Xu S; Wang J; Huang L; Cheng L; Li H
    Funct Integr Genomics; 2023 Aug; 23(3):259. PubMed ID: 37528306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1.
    Gong J; Zhu B; Murshid A; Adachi H; Song B; Lee A; Liu C; Calderwood SK
    J Immunol; 2009 Sep; 183(5):3092-8. PubMed ID: 19641135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
    Beilmann-Lehtonen I; Kasurinen J; Hagström J; Kaprio T; Böckelman C; Haglund C
    PLoS One; 2023; 18(1):e0280085. PubMed ID: 36649244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins.
    Habich C; Baumgart K; Kolb H; Burkart V
    J Immunol; 2002 Jan; 168(2):569-76. PubMed ID: 11777948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
    Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
    Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
    Quintana FJ; Carmi P; Mor F; Cohen IR
    Arthritis Rheum; 2004 Nov; 50(11):3712-20. PubMed ID: 15529360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.
    Chang CL; Tsai YC; He L; Wu TC; Hung CF
    Cancer Res; 2007 Oct; 67(20):10047-57. PubMed ID: 17942939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity.
    Yu X; Liu W; Chen S; Cheng X; Paez PA; Sun T; Yuan F; Wei C; Landry JW; Poklepovic AS; Bear HD; Subjeck JR; Repasky E; Guo C; Wang XY
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33468554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of heat shock protein (HSP) family HSP 60, 70 and 90alpha in colorectal cancer tissues and their correlations to pathohistological characteristics].
    Zhang WL; Gao XQ; Han JX; Wang GQ; Yue LT
    Ai Zheng; 2009 Jun; 28(6):612-8. PubMed ID: 19635199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp70 modulates immune response in pancreatic cancer through dendritic cells.
    Giri B; Sharma P; Jain T; Ferrantella A; Vaish U; Mehra S; Garg B; Iyer S; Sethi V; Malchiodi Z; Signorelli R; Jacob HKC; George J; Sahay P; Bava EP; Dawra R; Ramakrishnan S; Saluja A; Dudeja V
    Oncoimmunology; 2021; 10(1):1976952. PubMed ID: 34552825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression.
    Sun Y; Xiao W; Yu Y; Jiang Y; Xiao Z; Huang D; Zhong T; Li J; Xiang X; He Y; Li Z
    Exp Cell Res; 2023 May; 426(2):113565. PubMed ID: 36958650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.
    Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY
    Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of stromal PD-L1 and tumoral nuclear β-catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma.
    Takahashi H; Watanabe H; Hashimura M; Matsumoto T; Yokoi A; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Saegusa M
    J Pathol Clin Res; 2022 Sep; 8(5):458-469. PubMed ID: 35762092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
    Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.